345 related articles for article (PubMed ID: 32308747)
1. A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation.
Yang HH; Duan JX; Liu SK; Xiong JB; Guan XX; Zhong WJ; Sun CC; Zhang CY; Luo XQ; Zhang YF; Chen P; Hammock BD; Hwang SH; Jiang JX; Zhou Y; Guan CX
Theranostics; 2020; 10(11):4749-4761. PubMed ID: 32308747
[No Abstract] [Full Text] [Related]
2. A COX-2/sEH dual inhibitor PTUPB ameliorates cecal ligation and puncture-induced sepsis in mice via anti-inflammation and anti-oxidative stress.
Zhang YF; Sun CC; Duan JX; Yang HH; Zhang CY; Xiong JB; Zhong WJ; Zu C; Guan XX; Jiang HL; Hammock BD; Hwang SH; Zhou Y; Guan CX
Biomed Pharmacother; 2020 Jun; 126():109907. PubMed ID: 32114358
[TBL] [Abstract][Full Text] [Related]
3. Epoxyeicosatrienoic acids inhibit the activation of NLRP3 inflammasome in murine macrophages.
Luo XQ; Duan JX; Yang HH; Zhang CY; Sun CC; Guan XX; Xiong JB; Zu C; Tao JH; Zhou Y; Guan CX
J Cell Physiol; 2020 Dec; 235(12):9910-9921. PubMed ID: 32452554
[TBL] [Abstract][Full Text] [Related]
4. COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence.
Zhang CY; Duan JX; Yang HH; Sun CC; Zhong WJ; Tao JH; Guan XX; Jiang HL; Hammock BD; Hwang SH; Zhou Y; Guan CX
FEBS J; 2020 Apr; 287(8):1666-1680. PubMed ID: 31646730
[TBL] [Abstract][Full Text] [Related]
5. COX-2/sEH Dual Inhibitor Alleviates Hepatocyte Senescence in NAFLD Mice by Restoring Autophagy through Sirt1/PI3K/AKT/mTOR.
Zhang CY; Tan XH; Yang HH; Jin L; Hong JR; Zhou Y; Huang XT
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897843
[TBL] [Abstract][Full Text] [Related]
6. PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice.
Sun CC; Zhang CY; Duan JX; Guan XX; Yang HH; Jiang HL; Hammock BD; Hwang SH; Zhou Y; Guan CX; Liu SK; Zhang J
Biochem Biophys Res Commun; 2020 Mar; 523(4):1020-1026. PubMed ID: 31973813
[TBL] [Abstract][Full Text] [Related]
7. Aloperine alleviates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome activation.
Zeng J; Liu J; Huang JH; Fu SP; Wang XY; Xi C; Cui YR; Qu F
Int Immunopharmacol; 2023 Jul; 120():110142. PubMed ID: 37210910
[TBL] [Abstract][Full Text] [Related]
8. Fn14 exacerbates acute lung injury by activating the NLRP3 inflammasome in mice.
Guan XX; Yang HH; Zhong WJ; Duan JX; Zhang CY; Jiang HL; Xiang Y; Zhou Y; Guan CX
Mol Med; 2022 Jul; 28(1):85. PubMed ID: 35907805
[TBL] [Abstract][Full Text] [Related]
9. Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.
Shan M; Wan H; Ran L; Ye J; Xie W; Lu J; Hu X; Deng S; Zhang W; Chen M; Wang F; Guo Z
Drug Des Devel Ther; 2024; 18():1369-1384. PubMed ID: 38681210
[TBL] [Abstract][Full Text] [Related]
10. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages.
Zhou Y; Zhang CY; Duan JX; Li Q; Yang HH; Sun CC; Zhang J; Luo XQ; Liu SK
Biomed Pharmacother; 2020 Jan; 121():109596. PubMed ID: 31731193
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glycolysis alleviates lipopolysaccharide-induced acute lung injury in a mouse model.
Zhong WJ; Yang HH; Guan XX; Xiong JB; Sun CC; Zhang CY; Luo XQ; Zhang YF; Zhang J; Duan JX; Zhou Y; Guan CX
J Cell Physiol; 2019 Apr; 234(4):4641-4654. PubMed ID: 30256406
[TBL] [Abstract][Full Text] [Related]
13. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
[TBL] [Abstract][Full Text] [Related]
14. Loganin alleviates sepsis-induced acute lung injury by regulating macrophage polarization and inhibiting NLRP3 inflammasome activation.
Zhang J; Wang C; Wang H; Li X; Xu J; Yu K
Int Immunopharmacol; 2021 Jun; 95():107529. PubMed ID: 33744777
[TBL] [Abstract][Full Text] [Related]
15. RIP3 dependent NLRP3 inflammasome activation is implicated in acute lung injury in mice.
Chen J; Wang S; Fu R; Zhou M; Zhang T; Pan W; Yang N; Huang Y
J Transl Med; 2018 Aug; 16(1):233. PubMed ID: 30126430
[TBL] [Abstract][Full Text] [Related]
16. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
17. Tangeretin attenuates acute lung injury in septic mice by inhibiting ROS-mediated NLRP3 inflammasome activation via regulating PLK1/AMPK/DRP1 signaling axis.
Liu Y; Zhang Y; You G; Zheng D; He Z; Guo W; Antonina K; Shukhrat Z; Ding B; Zan J; Zhang Z
Inflamm Res; 2024 Jan; 73(1):47-63. PubMed ID: 38147126
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M
Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555
[TBL] [Abstract][Full Text] [Related]
19. Glibenclamide alleviates inflammation in oleic acid model of acute lung injury through NLRP3 inflammasome signaling pathway.
Chen H; Ding Y; Chen W; Feng Y; Shi G
Drug Des Devel Ther; 2019; 13():1545-1554. PubMed ID: 31123394
[No Abstract] [Full Text] [Related]
20. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation.
Yang JW; Mao B; Tao RJ; Fan LC; Lu HW; Ge BX; Xu JF
J Cell Mol Med; 2020 Nov; 24(21):12716-12725. PubMed ID: 32977368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
